Canada
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
59.92%
|
Dec. 31, 2023 | USD 9.40 | -4.39% |
|
Canada |
|
2 |
13.98%
|
Dec. 31, 2023 | USD 30.84 | 0.81% |
|
Canada |
|
3 |
9.71%
|
Dec. 31, 2023 | USD 23.94 | 0.98% |
|
Canada |
|
4 |
6.01%
|
Dec. 31, 2023 | USD 13.41 | 0.42% |
|
Canada |
|
5 |
4.87%
|
Dec. 31, 2023 | USD 122.81 | -2.58% |
|
Canada |
|
6 |
0.09%
|
March 31, 2024 | USD 3.11 | 5.40% |
|
Canada |
|
7 |
-2.59%
|
Dec. 31, 2023 | USD 1.51 | -0.70% |
|
Canada |
|
8 |
-4.00%
|
Dec. 31, 2023 | USD 17.23 | -0.99% |
|
Canada |
|
9 |
-4.45%
|
Dec. 31, 2023 | USD 7.49 | 1.16% |
|
Canada |
|
10 |
-6.70%
|
Dec. 31, 2023 | USD 3.69 | 0.40% |
|
Canada |
|
11 |
-17.06%
|
Dec. 31, 2023 | USD 2.82 | -2.42% |
|
Canada |
|
12 |
-22.05%
|
March 31, 2024 | USD 3.94 | -2.21% |
|
Canada |
|
13 |
-28.43%
|
Sept. 30, 2024 | USD 1.53 | -2.45% |
|
Canada |
|
14 |
-28.79%
|
Nov. 30, 2023 | USD 1.71 | 4.46% |
|
Canada |
|
15 |
-31.56%
|
May 31, 2024 | USD 1.18 | -0.37% |
|
Canada |
|
16 |
-44.08%
|
Dec. 31, 2023 | USD 2.70 | 2.33% |
|
Canada |
|
17 |
-44.14%
|
Dec. 31, 2023 | USD 7.55 | -2.83% |
|
Canada |
|
18 |
-63.49%
|
Dec. 31, 2023 | USD 0.94 | 1.68% |
|
Canada |
|
19 |
-137.27%
|
Sept. 30, 2024 | USD 4.08 | -3.32% |
|
Canada |
|
20 |
-156.87%
|
Dec. 31, 2023 | USD 13.62 | -2.44% |
|
Canada |
|
21 |
-158.63%
|
March 31, 2024 | USD 2.23 | -6.78% |
|
Canada |
|
22 |
-201.79%
|
Dec. 31, 2023 | USD 1.27 | -3.05% |
|
Canada |
|
23 |
-398.62%
|
Dec. 31, 2023 | USD 7.26 | -2.32% |
|
Canada |
|
24 |
-457.67%
|
Dec. 31, 2023 | USD 2.77 | -7.67% |
|
Canada |
|
25 |
-1,198.00%
|
Dec. 31, 2023 | USD 0.11 | 0.09% |
|
Canada |
|
26 |
-1,474.54%
|
Nov. 30, 2024 | USD 1.93 | -6.31% |
|
Canada |
|
27 |
-5,968.50%
|
Dec. 31, 2023 | USD 1.96 | -0.51% |
|
Canada |
The Pharmaceuticals company in Canada with the highest EBT Margin is Cipher Pharmaceuticals Inc. (Toronto Stock Exchange: CPH.TO) at 59.92%.
The Pharmaceuticals company in Canada with the lowest EBT Margin is Milestone Pharmaceuticals Inc. (NasdaqGS: MIST) at -5,968.50%.
The top 10 Pharmaceuticals companies in Canada by EBT Margin are Cipher Pharmaceuticals Inc., Andlauer Healthcare Group Inc., Jamieson Wellness Inc., Savaria Corporation, Loblaw Companies Limited, Medexus Pharmaceuticals Inc., CareRx Corporation, Bausch + Lomb Corporation, Bausch Health Companies Inc. and Knight Therapeutics Inc..
The bottom 10 Pharmaceuticals companies in Canada by EBT Margin are Milestone Pharmaceuticals Inc., Lexaria Bioscience Corp., Ondine Biomedical Inc., AbCellera Biologics Inc., Profound Medical Corp., Repare Therapeutics Inc., Canopy Growth Corporation, Zymeworks Inc., InMed Pharmaceuticals Inc. and Flora Growth Corp..